Mahmoud A. Younis

Ultra-small lipid nanoparticles encapsulating sorafenib and midkine-siRNA selectively-eradicate sorafenib-resistant hepatocellular carcinoma in vivo

Mahmoud A. Younis, Ikramy A. Khalil, Yaser Hosny Ali Elewa et al. · Journal of Controlled Release · 2021 · 110 citations

Nanoparticles, Nanomedicine, Engineering +6

A Multifunctional Lipid-Based Nanodevice for the Highly Specific Codelivery of Sorafenib and Midkine siRNA to Hepatic Cancer Cells

Mahmoud A. Younis, Ikramy A. Khalil, Mahmoud M. Abd Elwakil et al. · Molecular Pharmaceutics · 2019 · 66 citations

Inhibitory role of Annexin A1 in pathological bone resorption and therapeutic implications in periprosthetic osteolysis

Hend Alhasan, Mohamad Alaa Terkawi, Gen Matsumae et al. · Nature Communications · 2022 · 56 citations · Full text

Self-homing nanocarriers for mRNA delivery to the activated hepatic stellate cells in liver fibrosis

Mahmoud A. Younis, Yusuke Sato, Yaser Hosny Ali Elewa et al. · Journal of Controlled Release · 2022 · 43 citations

Cell-based Drug Delivery, Nanomedicine, Liver Fibrosis +12

Reprogramming activated hepatic stellate cells by siRNA-loaded nanocarriers reverses liver fibrosis in mice

Mahmoud A. Younis, Yusuke Sato, Yaser Hosny Ali Elewa et al. · Journal of Controlled Release · 2023 · 29 citations

Liver Fibrosis, Engineering, Hepatic Stellate Cells +16